Raymond Vanholder, MD, PhD
University Hospital, Ghent
12
12
10
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+7 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Wim Van Biesen, MD, PhD
University Hospital, Ghent
Shared therapeutic areas:
Worked with same sponsors:
Melda Saglam, PhD
Hacettepe University
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Waqar ahmed awan, Phd
Riphah International University
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Michael S Avidan, MBBcH
Washington University School of Medicine
Shared therapeutic areas:
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
Ahmed Elshafeey, Ph.D. Pharma
Genuine Research Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis
Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Uremic Toxins in the Intensive Care Unit (ICU): Patients With Sepsis
Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis
Uremic Toxins in the ICU: Patients After Cardiac Surgery
Uremic Toxins of Patients With Acute Kidney Failure
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.
Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis
Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study
All 12 trials loaded